TY - JOUR
T1 - Side-by-side comparison of commonly used biomolecules that differ in size and affinity on tumor uptake and internalization
AU - Leelawattanachai, Jeerapond
AU - Kwon, Keon Woo
AU - Michael, Praveesuda
AU - Ting, Richard
AU - Kim, Ju Young
AU - Jin, Moonsoo M.
N1 - Funding Information:
This work was supported by NIH R01CA178007, the Ministry of Science, ICT & Future Planning (#121S-4-3-0353), Republic of Korea, and the Royal Thai Government Scholarship (J.L.). We thank Susan Daniel, Rasa Zarnegar, Jiahe Li, Xiaoyue Chen, Hsien-Wei Meng, Xuebo Hu, Pengcheng Bu, Sungkwon Kang, Nikolai Rakhilin, Johanna M. Dela Cruz, Carol J. Bayles, and Christine M. Peterson for insightful discussion and technical assistance.
Publisher Copyright:
© 2015 Leelawattanachai et al.
PY - 2015/4/22
Y1 - 2015/4/22
N2 - The ability to use a systemically injected agent to image tumor is influenced by tumor characteristics such as permeability and vascularity, and the size, shape, and affinity of the imaging agent. In this study, six different imaging biomolecules, with or without specificity to tumor, were examined for tumor uptake and internalization at the whole body, ex-vivo tissue, and cellular levels: antibodies, antibody fragments (Fab), serum albumin, and streptavidin. The time of peak tumor uptake was dependent solely on the size of molecules, suggesting that molecular size is the major factor that influences tumor uptake by its effect on systemic clearance and diffusion into tumor. Affinity to tumor antigen failed to augment tumor uptake of Fab above non-specific accumulation, which suggests that Fab fragments of typical monoclonal antibodies may fall below an affinity threshold for use as molecular imaging agents. Despite abundant localization into the tumor, albumin and streptavidin were not found on cell surface or inside cells. By comparing biomolecules differing in size and affinity, our study highlights that while pharmacokinetics are a dominant factor in tumor uptake for biomolecules, affinity to tumor antigen is required for tumor binding and internalization.
AB - The ability to use a systemically injected agent to image tumor is influenced by tumor characteristics such as permeability and vascularity, and the size, shape, and affinity of the imaging agent. In this study, six different imaging biomolecules, with or without specificity to tumor, were examined for tumor uptake and internalization at the whole body, ex-vivo tissue, and cellular levels: antibodies, antibody fragments (Fab), serum albumin, and streptavidin. The time of peak tumor uptake was dependent solely on the size of molecules, suggesting that molecular size is the major factor that influences tumor uptake by its effect on systemic clearance and diffusion into tumor. Affinity to tumor antigen failed to augment tumor uptake of Fab above non-specific accumulation, which suggests that Fab fragments of typical monoclonal antibodies may fall below an affinity threshold for use as molecular imaging agents. Despite abundant localization into the tumor, albumin and streptavidin were not found on cell surface or inside cells. By comparing biomolecules differing in size and affinity, our study highlights that while pharmacokinetics are a dominant factor in tumor uptake for biomolecules, affinity to tumor antigen is required for tumor binding and internalization.
UR - http://www.scopus.com/inward/record.url?scp=84930637136&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930637136&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0124440
DO - 10.1371/journal.pone.0124440
M3 - Article
C2 - 25901755
AN - SCOPUS:84930637136
VL - 10
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 4
M1 - e0124440
ER -